These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
128 related articles for article (PubMed ID: 31182063)
1. Aberrant expression of N-glycolyl GM3 ganglioside is associated with the aggressive biological behavior of human sarcomas. Pilco-Janeta D; De la Cruz Puebla M; Soriano J; Osorio M; Caballero I; Pérez AC; Savon L; Cremades N; Blanco R; Carr A BMC Cancer; 2019 Jun; 19(1):556. PubMed ID: 31182063 [TBL] [Abstract][Full Text] [Related]
2. N-Glycolyl GM3 ganglioside immunoexpression in oral mucosal melanomas of Chinese. Zhong Y; Wu Y; Li C; Tang J; Wang X; Ren G; Carr A; Pérez R; Guo W Oral Dis; 2012 Nov; 18(8):741-7. PubMed ID: 22574836 [TBL] [Abstract][Full Text] [Related]
3. Prognostic Significance of N-Glycolyl GM3 Ganglioside Expression in Non-Small Cell Lung Carcinoma Patients: New Evidences. Blanco R; Domínguez E; Morales O; Blanco D; Martínez D; Rengifo CE; Viada C; Cedeño M; Rengifo E; Carr A Patholog Res Int; 2015; 2015():132326. PubMed ID: 26634172 [TBL] [Abstract][Full Text] [Related]
4. Detection of N-glycolyl GM3 ganglioside in neuroectodermal tumors by immunohistochemistry: an attractive vaccine target for aggressive pediatric cancer. Scursoni AM; Galluzzo L; Camarero S; Lopez J; Lubieniecki F; Sampor C; Segatori VI; Gabri MR; Alonso DF; Chantada G; de Dávila MT Clin Dev Immunol; 2011; 2011():245181. PubMed ID: 21941577 [TBL] [Abstract][Full Text] [Related]
5. Prognostic Role of 14F7 Mab Immunoreactivity against N-Glycolyl GM3 Ganglioside in Colon Cancer. Lahera T; Calvo A; Torres G; Rengifo CE; Quintero S; Arango Mdel C; Danta D; Vázquez JM; Escobar X; Carr A J Oncol; 2014; 2014():482301. PubMed ID: 24639871 [TBL] [Abstract][Full Text] [Related]
7. Immunoreactivity of the 14F7 Mab Raised against N-Glycolyl GM3 Ganglioside in Primary Lymphoid Tumors and Lymph Node Metastasis. Blanco R; Blanco D; Quintana Y; Escobar X; Rengifo CE; Osorio M; Gutiérrez Z; Lamadrid J; Cedeño M; Frómeta M; Carr A; Rengifo E Patholog Res Int; 2013; 2013():920972. PubMed ID: 24381785 [TBL] [Abstract][Full Text] [Related]
8. Immunoreactivity of the 14F7 Mab raised against N-Glycolyl GM3 Ganglioside in retinoblastoma tumours. Torbidoni AV; Scursoni A; Camarero S; Segatori V; Gabri M; Alonso D; Chantada G; de Dávila MT Acta Ophthalmol; 2015 Jun; 93(4):e294-300. PubMed ID: 25403557 [TBL] [Abstract][Full Text] [Related]
10. Prognostic Significance of Tumor Tissue NeuGcGM3 Ganglioside Expression in Patients Receiving Racotumomab Immunotherapy. Uskent N; Ayla S; Molinas Mandel N; Ozkan M; Teomete M; Baloglu H; Aydıncer C; Yergok H; Dogan E; Berk B; Yazar A J Oncol; 2020; 2020():1360431. PubMed ID: 32670370 [TBL] [Abstract][Full Text] [Related]
11. Immunoreactivity of the 14F7 Mab Raised against N-Glycolyl GM3 Ganglioside in Epithelial Malignant Tumors from Digestive System. Blanco R; Rengifo E; Cedeño M; Rengifo CE; Alonso DF; Carr A ISRN Gastroenterol; 2011; 2011():645641. PubMed ID: 21991524 [TBL] [Abstract][Full Text] [Related]
12. Modified staging system for extremity soft tissue sarcomas. Ramanathan RC; A'Hern R; Fisher C; Thomas JM Ann Surg Oncol; 1999; 6(1):57-69. PubMed ID: 10030416 [TBL] [Abstract][Full Text] [Related]
13. Cancer vaccines: an update with special focus on ganglioside antigens. Bitton RJ; Guthmann MD; Gabri MR; Carnero AJ; Alonso DF; Fainboim L; Gomez DE Oncol Rep; 2002; 9(2):267-76. PubMed ID: 11836591 [TBL] [Abstract][Full Text] [Related]
15. Clinical evidences of GM3 (NeuGc) ganglioside expression in human breast cancer using the 14F7 monoclonal antibody labelled with (99m)Tc. Oliva JP; Valdés Z; Casacó A; Pimentel G; González J; Alvarez I; Osorio M; Velazco M; Figueroa M; Ortiz R; Escobar X; Orozco M; Cruz J; Franco S; Díaz M; Roque L; Carr A; Vázquez AM; Mateos C; Rubio MC; Pérez R; Fernández LE Breast Cancer Res Treat; 2006 Mar; 96(2):115-21. PubMed ID: 16322892 [TBL] [Abstract][Full Text] [Related]
16. Clinicopathological significance of orphan nuclear receptor Nurr1 expression in gastric cancer. Guo J; Zu G; Zhou T; Xing J; Wang Z Clin Transl Oncol; 2015 Oct; 17(10):788-94. PubMed ID: 26022133 [TBL] [Abstract][Full Text] [Related]
17. Engineering the binding site of an antibody against N-glycolyl GM3: from functional mapping to novel anti-ganglioside specificities. Rojas G; Pupo A; Gómez S; Krengel U; Moreno E ACS Chem Biol; 2013 Feb; 8(2):376-86. PubMed ID: 23138862 [TBL] [Abstract][Full Text] [Related]
18. The retinoblastoma family member pRb2/p130 is an independent predictor of survival in human soft tissue sarcomas. Masciullo V; Berardengo E; Boglione A; Sgambato A; Bernardi A; Forni M; Linari A; Cito L; Scambia G; Comandone A; Giordano A Clin Cancer Res; 2008 Aug; 14(15):4775-9. PubMed ID: 18676747 [TBL] [Abstract][Full Text] [Related]
19. Immunohistochemical Reactivity of the 14F7 Monoclonal Antibody Raised against N-Glycolyl GM3 Ganglioside in Some Benign and Malignant Skin Neoplasms. Blanco R; Rengifo E; Rengifo CE; Cedeño M; Frómeta M; Carr A ISRN Dermatol; 2011; 2011():848909. PubMed ID: 22363862 [TBL] [Abstract][Full Text] [Related]
20. Synovial sarcoma. A Scandinavian Sarcoma Group project. Skytting B Acta Orthop Scand Suppl; 2000 Apr; 291():1-28. PubMed ID: 10862210 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]